Deep Brain Stimulation Market is expected to reach US$ 1,155.37 million by 2030

Publisher: The Insight Partners

Dual Channel Deep Brain Stimulation Segment, by Product, to Dominate Deep Brain Stimulation During 2022–2030

According to our new research study on "Deep Brain Stimulation Market Forecast to 2030 – COVID-19 Impact and Global Analysis – by Product, Application, and End User," the market is expected to grow from US$ 603.52 million in 2022 and is expected to reach a value of US$ 1,155.37 million by 2030; it is anticipated to record a CAGR of 8.5% from 2022 to 2030. Key factors driving the deep brain stimulation market growth are the rising prevalence of neurological disorders and increasing demand for minimally invasive surgery are driving the market growth. However, side effects associated with deep brain stimulation hinder the market growth.

Deep Brain Stimulation Market, by Geography, 2022 (%)

To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPHE100000996 Source: The Insight Partners Analysis

The deep brain stimulation market, by product, is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software & systems. The dual channel deep brain stimulator segment held the largest market share in 2022. Moreover, the same segment is anticipated to register the highest CAGR of 9.5% during the forecast period. Dual channel DBS offers the best overall support as well as exhibits greater effectiveness in reducing patient tremors. The growing adoption of dual channel DBS for the treatment of various neurological disorders, such as dystonia, Parkinson’s disease, Alzheimer’s disease, and epilepsy, is a key factor fueling the segment growth. As per an article published in the Journal of NeuroEngineering and Rehabilitation on March 2020, titled "Advances in neuroprosthetic management of foot drop: a review,"—multichannel stimulation, also known as dual channel stimulation, is advantageous over a single channel stimulation. In multichannel systems, it can have a single anode and several independent cathodes or have anodes and cathodes that are galvanically isolated. Various advancements in multichannel systems allow controlling numerous muscle groups, improving their applicability to a wider range of pathologies. The development of multichannel systems has also positively contributed to the management of muscle fatigue, as in the case of asynchronous stimulation. Moreover, product approvals are propelling the growth of the dual channel deep brain stimulators segment. For instance, in January 2020, Abbott’s Infinity DBS system received FDA approval for the treatment of Parkinson's disease.

Abbott Laboratories, Aleva Neurotherapeutics SA, Medtronic Plc, Beijing PINS Medical Co Ltd, Boston Scientific Corp, Newronika SpA, and SceneRay Co Ltd, are among the key companies operating in the deep brain stimulation market. The companies have been implementing various strategies that contributed to their growth and led to various changes in the market. The companies have utilized both organic strategies (such as launches, expansion, and product approvals) and inorganic strategies (such as product launches, partnerships, and collaborations).

For instance, in July 2023, Boston Scientific Corporation received US Food and Drug Administration (FDA) approval for the Vercise Neural Navigator 5 Software, which, when used as part of the Vercise Genus Deep Brain Stimulation (DBS) Systems, can provide clinicians with simple and actionable data for efficient programming in the treatment of people suffering from Parkinson’s disease or essential tremor.

The report segments the deep brain stimulation market as follows:

Based on product, the deep brain stimulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software & systems. Based on application, the global deep brain stimulation market is segmented into Parkinson's disease, tremor, Alzheimer’s disease, dystonia, epilepsy, and others. The deep brain stimulation market, based on end user, is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. Based on geography, the deep brain stimulation market is segmented into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Contact Us
Contact Us: The Insight Partners 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com